220 related articles for article (PubMed ID: 11770119)
1. Treatment of visceral leishmaniasis.
Sundar S
Med Microbiol Immunol; 2001 Nov; 190(1-2):89-92. PubMed ID: 11770119
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance in Indian visceral leishmaniasis.
Sundar S
Trop Med Int Health; 2001 Nov; 6(11):849-54. PubMed ID: 11703838
[TBL] [Abstract][Full Text] [Related]
3. The treatment of visceral leishmaniasis: safety and efficacy.
Jha RK; Sah AK; Shah DK; Sah P
JNMA J Nepal Med Assoc; 2013; 52(192):645-51. PubMed ID: 25327244
[TBL] [Abstract][Full Text] [Related]
4. Management of visceral leishmaniasis: Indian perspective.
Agrawal S; Rai M; Sundar S
J Postgrad Med; 2005; 51 Suppl 1():S53-7. PubMed ID: 16519257
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
[TBL] [Abstract][Full Text] [Related]
6. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
Manfredi R; Marinacci G; Calza L; Passarini B
Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
[No Abstract] [Full Text] [Related]
7. Visceral leishmaniasis - current therapeutic modalities.
Sundar S; Chatterjee M
Indian J Med Res; 2006 Mar; 123(3):345-52. PubMed ID: 16778315
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the treatment of visceral leishmaniasis.
Davidson RN; Croft SL
Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
[No Abstract] [Full Text] [Related]
9. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.
Olliaro PL; Guerin PJ; Gerstl S; Haaskjold AA; Rottingen JA; Sundar S
Lancet Infect Dis; 2005 Dec; 5(12):763-74. PubMed ID: 16310148
[TBL] [Abstract][Full Text] [Related]
10. Leishmaniasis: an update of current pharmacotherapy.
Sundar S; Chakravarty J
Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
[TBL] [Abstract][Full Text] [Related]
11. Visceral Leishmaniasis-Optimum Treatment Options in Children.
Sundar S; Agarwal D
Pediatr Infect Dis J; 2018 May; 37(5):492-494. PubMed ID: 29280784
[TBL] [Abstract][Full Text] [Related]
12. Drug combinations for visceral leishmaniasis.
Olliaro PL
Curr Opin Infect Dis; 2010 Dec; 23(6):595-602. PubMed ID: 20871400
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the management of visceral leishmaniasis.
Sundar S; Kumar A
Indian Pediatr; 2005 Jun; 42(6):523-6. PubMed ID: 15995268
[No Abstract] [Full Text] [Related]
14. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
Mishra M
J Assoc Physicians India; 1995 Apr; 43(4):306. PubMed ID: 8713286
[No Abstract] [Full Text] [Related]
15. Leishmaniasis: current status of available drugs and new potential drug targets.
Singh N; Kumar M; Singh RK
Asian Pac J Trop Med; 2012 Jun; 5(6):485-97. PubMed ID: 22575984
[TBL] [Abstract][Full Text] [Related]
16. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
[TBL] [Abstract][Full Text] [Related]
17. Amphotericin B in visceral leishmaniasis.
Jha BB
Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838
[No Abstract] [Full Text] [Related]
18. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral miltefosine in visceral leishmaniasis in rural West Bengal, India.
Patra P; Guha SK; Maji AK; Saha P; Ganguly S; Chakraborty A; Kundu PK; Sarker S; Ray K
Indian J Pharmacol; 2012; 44(4):500-3. PubMed ID: 23087513
[TBL] [Abstract][Full Text] [Related]
20. Oral miltefosine for Indian visceral leishmaniasis.
Sundar S; Jha TK; Thakur CP; Engel J; Sindermann H; Fischer C; Junge K; Bryceson A; Berman J
N Engl J Med; 2002 Nov; 347(22):1739-46. PubMed ID: 12456849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
